Intellia Therapeutics, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Intellia Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Intellia Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -42.4 %, a 26.2% decline year-over-year.
  • Intellia Therapeutics, Inc. annual Return On Assets for 2023 was -36.4 %, a 5.57% increase from 2022.
  • Intellia Therapeutics, Inc. annual Return On Assets for 2022 was -38.6 %, a 44.6% decline from 2021.
  • Intellia Therapeutics, Inc. annual Return On Assets for 2021 was -26.7 %, a 3.61% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -36.4 +2.15 +5.57% Jan 1, 2023 Dec 31, 2023
2022 -38.6 -11.9 -44.6% Jan 1, 2022 Dec 31, 2022
2021 -26.7 +1 +3.61% Jan 1, 2021 Dec 31, 2021
2020 -27.7 +110 +79.9% Jan 1, 2020 Dec 31, 2020
2019 -138 -113 -452% Jan 1, 2019 Dec 31, 2019
2018 -25 -1.86 -8.05% Jan 1, 2018 Dec 31, 2018
2017 -23.1 -10.3 -80.1% Jan 1, 2017 Dec 31, 2017
2016 -12.8 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.